Today, Atreon Orthopedics announced that the U.S. Food and Drug Administration (FDA) has cleared its proprietary product, the Rotium® Bioresorbable Wick, which is intended to be used in conjunction with suture anchors for the reattachment of tendon to bone in rotator cuff repairs.
The Rotium® Bioresorbable Wick is a a non-woven, microfiber matrix comprising biodegradable polymer fibers that mimic the extracellular matrix structure. Rotium® supports cellular infiltration and migration, and facilitates functional tissue regeneration.
